Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,378 | 3,026 | 1,723 | 3,196 | 4,945 |
| Marketable Securities | 0 | 98 | 227 | 154 | 88 |
| Receivables | 92 | 137 | 225 | 107 | 251 |
| Inventories | 1,925 | 2,636 | 2,641 | 2,651 | 3,748 |
| Other current assets | 188 | 220 | 262 | 358 | 322 |
| TOTAL | $3,583 | $6,117 | $5,078 | $6,466 | $9,354 |
| Non-Current Assets | |||||
| PPE Net | 5,268 | 7,947 | 8,104 | 8,213 | 8,309 |
| Intangibles | 1,182 | 1,181 | 1,179 | 1,170 | 1,022 |
| Other Non-Current Assets | 1,226 | 1,261 | 1,312 | 1,329 | 1,385 |
| TOTAL | $7,676 | $10,389 | $10,595 | $10,712 | $10,716 |
| Total Assets | $11,259 | $16,506 | $15,673 | $17,178 | $20,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 648 | 549 | 672 | 530 | 466 |
| Accrued Expenses | 1,288 | 1,557 | 1,459 | 1,368 | 890 |
| TOTAL | $1,936 | $2,106 | $2,131 | $1,898 | $1,356 |
| Non-Current Liabilities | |||||
| Long Term Debt | 138 | 139 | 140 | 141 | 141 |
| Other Non-Current Liabilities | 132 | 163 | 200 | 228 | 256 |
| TOTAL | $270 | $302 | $340 | $369 | $397 |
| Total Liabilities | $2,206 | $2,408 | $2,471 | $2,267 | $1,753 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,734 | 63,734 | 53,917 | N/A | 53,077 |
| Common Shares | 123,258 | 122,732 | 119,322 | 118,965 | 118,382 |
| Retained earnings | -110,780 | -105,191 | -102,740 | -100,665 | -96,635 |
| Other shareholders' equity | -3,425 | -3,443 | -3,380 | -3,389 | -3,430 |
| TOTAL | $9,053 | $14,098 | $13,202 | $14,911 | $18,317 |
| Total Liabilities And Equity | $11,259 | $16,506 | $15,673 | $17,178 | $20,070 |